U.S. FDA issued an EUA to Ortho-Clinical Diagnostics for VITROS Anti-SARS-CoV-2 IgG quantitative test
On Jul. 9, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Ortho-Clinical…
On Jul. 9, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Ortho-Clinical…
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
On Jul. 8, 2021, access to the worldメs largest browsable resource linking rare protein-coding genetic variants to human…
On Jul. 8, 2021, Pfizer and BioNTech announced encouraging data in the ongoing booster trial of a third…
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…
On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…
On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…
On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyメs Investigational…
On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…
On Jun. 30, 2021, CureVac announced results from the final analysis of its 40,000 subject international pivotal Phase…
On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…
On Jun. 30, 2021, XPhyto announced that it had signed a master supply agreement with Beovita and Tackleberries,…
On Jun. 30, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Clover…
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…
On Jun. 29, 2021, Altimmune announced phase 1 AdCOVID clinical trial data that showed AdCOVID appeared to be…
On Jun. 29, 2021, VBI Vaccines announced positive Phase 1 data from its Phase 1/2 trial of the…
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
On Jun. 28, 2021, Meridian Bioscience announced that it had re-submitted its application for Emergency Use Authorization (EUA)…
Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…
On Jun. 25, 2021, Roche announced that the Food and Drug Administration (FDA) has issued an Emergency Use…
On Jun. 24, 2021, researchers from the University of Oxford released their findings about the so-called ムcorrelates of…
On Jun. 23, 2021, the National Institutes of Health announced that an observational study had begun to evaluate…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 22, 2021, National Institutes of Health researchers reported that the prevalence of COVID-19 in the U.S….
On Jun. 22, 2021, BioReference Laboratories, an OPKO Health company, announced a COVID-19 testing program for U.S. based…
On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…